CLINICAL_TRIALS
trial_result
· 2018-01-18
Clinical Trial Update: A Moderate to Severe Rheumatoid Arthritis Study [Phase 3]
Summary
Phase 3 clinical trial in moderate to severe rheumatoid arthritis completed, with results posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Eli Lilly and Company | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2018-01-18